SLDB logo
SLDB NASDAQ US

Solid Biosciences Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jan 2018
$7.49
▲ +$0.11 (+1.49%)
Vol 808K
3
Quality Score
fail
Mkt Cap
$439.4M
ROE
-73.6%
Margin
-588.3%
D/E
0.13
Beta
2.68
52W
$2–$7

Wall Street Consensus

20 analysts · Apr 2026
8
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
95.0%
Buy Rating

Price Chart

Similar Stocks

JBIO
Jade Biosciences Inc
$709.8M
KURA
Kura Oncology Inc
$904.1M
VOR
Vor Biopharma Inc
$286.6M
SLS
Sellas Life Sciences Group Inc
$537.0M
MGTX
MeiraGTx Holdings PLC
$639.9M
BBOT
BridgeBio Oncology Therapeutics Inc
P/E 212.3
$1.0B
REPL
Replimune Group Inc
$762.5M
DSGN
Design Therapeutics Inc
$534.3M

Earnings

Beat rate: 20.0%
Next Report May 13, 2026
EPS Estimate: $-0.46
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.46 — —
Dec 2025 $-0.53 $-0.53 $0.00
Sep 2025 $-0.45 $-0.48 $-0.03
Jun 2025 $-0.51 $-0.42 +$0.09

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -71.9% -71.9% -71.9% -71.9% -73.6% -73.6%
P/E (TTM) — — — — — —
Net Margin — -588.3% -588.3% -588.3% -588.3% -588.3%
Gross Margin — — — — — —
D/E Ratio 0.37 0.37 0.37 0.37 0.13 0.13
Current Ratio 9.34 9.34 9.34 9.34 6.74 6.74

Key Ratios

ROA (TTM)
-60.0%
P/S (TTM)
29.71
P/B
1.2
EPS (TTM)
$-2.49
CF/Share
$-4.97
52W High
$7.37
52W Low
$2.41
$2.41 52-Week Range $7.37

How does SLDB compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

SLDB AAPG ABEO ABOS ABP

SLDB valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
29.7
▲ 131% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.2
▼ 53% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

SLDB profitability vs Biotechnology peers

ROE
-73.6%
▼ 9% below peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-588.3%
▼ 105% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-60.0%
▼ 28% below peers (-46.7%)
vs Peers
vs Industry
Weak

SLDB financial health vs Biotechnology peers

D/E ratio
0.1
▼ 0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
6.7
▲ 52% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
2.7
▲ 177% above peers (1.0)
vs Peers
vs Industry
More volatile

SLDB fundamentals radar

SLDB Peer median Industry

SLDB profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SLDB vs peers: key metrics

Latest News

No related news yet